Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.
Olliaro P, Grogl M, Boni M, Carvalho EM, Chebli H, Cisse M, Diro E, Fernandes Cota G, Erber AC, Gadisa E, Handjani F, Khamesipour A, Llanos-Cuentas A, López Carvajal L, Grout L, Lmimouni BE, Mokni M, Nahzat MS, Ben Salah A, Ozbel Y, Pascale JM, Rizzo Molina N, Rode J, Romero G, Ruiz-Postigo JA, Gore Saravia N, Soto J, Uzun S, Mashayekhi V, Vélez ID, Vogt F, Zerpa O, Arana B. Olliaro P, et al. Among authors: arana b. PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0006141. doi: 10.1371/journal.pntd.0006141. eCollection 2018 Jan. PLoS Negl Trop Dis. 2018. PMID: 29329311 Free PMC article.
Chemotherapy of cutaneous leishmaniasis: a review.
Arana B, Rizzo N, Diaz A. Arana B, et al. Med Microbiol Immunol. 2001 Nov;190(1-2):93-5. doi: 10.1007/s004300100089. Med Microbiol Immunol. 2001. PMID: 11770121 Review.
Miltefosine for new world cutaneous leishmaniasis.
Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H. Soto J, et al. Among authors: arana ba. Clin Infect Dis. 2004 May 1;38(9):1266-72. doi: 10.1086/383321. Epub 2004 Apr 9. Clin Infect Dis. 2004. PMID: 15127339 Clinical Trial.
Visceral leishmaniasis: elimination with existing interventions.
Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J. Matlashewski G, et al. Among authors: arana b. Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Lancet Infect Dis. 2011. PMID: 21453873 Review.
Research priorities for elimination of visceral leishmaniasis.
Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P. Matlashewski G, et al. Among authors: arana b. Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. Lancet Glob Health. 2014. PMID: 25433617 Free article. No abstract available.
Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent.
Olliaro PL, Shamsuzzaman TA, Marasini B, Dhariwal AC, Be-Nazir A, Mondal D, Banjara MR, Das P, Sundar S, Rijal S, Arana B, Alvar J, Argaw D, Peeling RW, Kroeger A, Matlashewski G. Olliaro PL, et al. Among authors: arana b. PLoS Negl Trop Dis. 2017 Jan 26;11(1):e0005190. doi: 10.1371/journal.pntd.0005190. eCollection 2017 Jan. PLoS Negl Trop Dis. 2017. PMID: 28125596 Free PMC article. No abstract available.
74 results